Melanotan II (MT-2, MT-II, Melanotan 2) is a synthetic analogue of the naturally occurring peptide hormone alpha-melanocyte-stimulating hormone (α-MSH). It was originally developed in the 1980s at the University of Arizona as a potential treatment for skin conditions by stimulating melanin production. The compound is a cyclic heptapeptide with a structure designed to mimic the effects of α-MSH, enhancing its stability and activity. Researchers have synthesized Melanotan II through solid-phase peptide synthesis, a method that allows for precise control over the peptide sequence and structure. Research on Melanotan II has primarily focused on its effects on skin pigmentation, sexual function, and appetite regulation. Researchers have observed that Melanotan II can induce skin tanning without exposure to UV radiation, making it a subject of interest for reducing skin cancer risk. Additionally, it has been investigated for its potential to enhance libido and erectile function, as well as its effects on appetite suppression. The mechanism of action of Melanotan II involves binding to melanocortin receptors, particularly MC1R and MC4R. These receptors are part of the G protein-coupled receptor family and play roles in skin pigmentation, energy homeostasis, and sexual function. By activating these receptors, Melanotan II can influence various physiological processes, including melanin production and sexual arousal. Pharmacokinetic studies of Melanotan II indicate that it has a half-life of approximately 1-2 hours when administered subcutaneously. The compound is relatively stable, but its bioavailability varies depending on the route of administration, with subcutaneous injection being the most effective. Current research on Melanotan II is limited, and it is not approved by regulatory agencies for therapeutic use. In the United States, the FDA has not approved Melanotan II as a drug, and it is often sold as a research chemical. Its regulatory status varies by country, and it remains a compound of interest for further investigation into its potential therapeutic applications.